American Transplant Congress Annual Meeting Coverage

Post-Transplant Bone Preservation Strategy Not Helpful

In a study, vitamin D and calcium supplementation for one year made no difference in bone mineral density.

Strategies Offer Similar Protection from CMV Disease

At-risk transplant recipients, however, have a lower risk of graft failure with prophylaxis than preemptive therapy.

Renal Transplants Improves Survival in the Elderly

Elderly patients who remain on dialysis are three times more likely to die than those who receive a deceased-donor kidney transplant.

Preemptive Transplants May Not Offer Survival Edge

BOSTON—Preemptive kidney transplantation may offer no survival advantage over kidney transplantation soon after dialysis initiation, according to new findings reported at the 2012 American Transplant Congress.

One-Year Outcomes Not Worse in Obese Kidney Donors

BOSTON—Researchers who examined renal outcomes in obese living kidney donors observed no increased incidence of hypertension, proteinuria, or renal dysfunction compared with non-obese donors at one year after nephrectomy.

Pediatric Renal Graft Survival Improving

BOSTON—Pediatric renal graft survival has improved over time, researchers reported at the 2012 American Transplant Congress.

Kids' Kidneys Can Work Well in Adult Recipients

BOSTON—Transplantation of kidneys from child donors into adult recipients can achieve good outcomes, according to researchers.

DGF Requiring More than One-Time Dialysis Raises Death Risk

PHILADELPHIA—Delayed graft function (DGF) requiring more than one-time dialysis is associated with increased death risk, according to findings presented at the 2011 American Transplant Congress.

Urine Biomarkers On First Day After Transplant Predict One-Year Outcomes

PHILADELPHIA—Higher urinary levels of two biomarkers on the first day following renal transplantation can predict poor graft function at one year, researchers reported at the 2011 American Transplant Congress.

Metabolic Syndrome Common After Renal Transplantation

PHILADELPHIA—Metabolic syndrome (MS) is present in 35%-40% of renal transplant recipients in the first five years post-transplant, new findings suggest.

Tx Patients Fail to Meet SBP Targets

PHILADELPHIA—Most renal transplant recipients (RTRs) fail to achieve recommended systolic blood pressure (SBP) levels despite being prescribed antihypertensive medications. Consequently, they may be at increased risk for cardiovascular disease (CVD), a study found.

Donor Kidney Weight Affects Transplant Outcomes

PHILADELPHIA—Renal transplants recipients who receive a heavier kidney relative to their body weight have better long-term graft survival and early graft function, researchers reported.

Obese Donors Not At Higher Renal Risk

Obese Donors Not At Higher Renal Risk

PHILADELPHIA—Obese kidney donors are not at elevated risk for renal dysfunction long term, but they may experience an increase in risk factors for cardiovascular disease (CVD), according to researchers.

ECG Findings May Identify Transplant Candidates at Higher Death Risk

ECG Findings May Identify Transplant Candidates at Higher Death Risk

PHILADELPHIA—Abnormalities revealed by electrocardiography (ECG) may predict which patients undergoing evaluation for a renal transplant are at higher risk of death, a study found. These abnormalities include prolonged PR or QTc intervals.

Delayed Graft Function Risk Not Lowered with High-Dose EPO

PHILADELPHIA—Short-term treatment with high-dose erythropoietin (EPO)—which is known to have tissue protective effects—does not decrease the incidence or duration of delayed graft function (DGF) or primary non-function (PNF) in recipients of kidneys from non-heart-beating donors, but it is associated with significantly better and faster renal recovery, a study found.